Introduction The Commissioning for Quality and Innovation (CQUIN) framework sets a 10% minimum and an ideal goal of 30% of acutely presenting patients over the age of 65 to receive frailty assessment scores. Early recognition of frailty helps mitigate risks such as deconditioning. This project aims to assess and improve the adoption of this standard in medical emergency admissions of a Birmingham district general hospital by working with medical admissions teams and frailty services and observing for associated outcome measures. Methodology PDSA methodology was used. Data was retrospectively
Introduction: Advance care planning is a process that allows individuals to make decisions about their future healthcare, including end-of-life care, by discussing and documenting their preferences, values, and goals with healthcare providers and loved ones. These are especially critical for patients with serious, life-limiting conditions or for frail older adults who may face unexpected health crises. It is a commonly recognised barrier to care planning however that senior doctors often do not have the time to complete it for all patients who require them and that junior doctors lack
Introduction Small, qualitative studies suggest discrepancies between older adults’ measured and self-perceived frailty. Any mismatch will have implications for frailty interventions and advanced care planning. We therefore, aimed to report the relationship between older adults’ self-perceived frailty and the Electronic Frailty Index (eFI), an objective screening tool measure of frailty, in a large, unselected cohort of older people. Method One thousand people aged ≥ 70 years, randomly selected from a single GP practice, were sent a survey, asking them to rate their own frailty using self
Introduction Advanced care planning (ACP) is particularly relevant for those living with frailty, who are at heightened risk of sudden health changes and loss of cognitive ability. The concepts of frailty and ACP are understood differently by older adults and health care professionals (HCPs). This abstract represents the qualitative component of a mixed methods study aiming to evaluate older people’s perspectives of frailty, including how and why they build self-perceptions of frailty, and their perceptions of ACP. Method Ten community dwelling, older adults, (aged seventy years plus)
Introduction: Polypharmacy—commonly defined as the use of five or more medications—is highly prevalent among older adults and is associated with increased risks of adverse drug events, falls, cognitive impairment, hospital admissions, and reduced quality of life. Inappropriate polypharmacy, where medications provide limited benefit or cause harm, represents a significant patient safety concern. Structured medication reviews (SMRs), supported by validated deprescribing tools such as STOPP/START and Beers Criteria, are essential for identifying and addressing potentially inappropriate
Introduction: Recommendations from the revised European Society of Cardiology (ESC) guidelines (2023) have changed how we manage decompensated heart failure (HF) in acute hospitals. Adherence to ESC guidelines is associated with reduced mortality, readmissions and improved quality of life ( www.escardio.org, 2023). This audit was conducted to compare our practice against the above ESC guidelines. Method: Two PDSA cycles were completed between July 2024 and April 2025 in the Acute Frailty Unit and two Elderly Care wards. Patients presenting with decompensated HF above 65 years were included
Introduction Older care home (CH) residents are particularly vulnerable to infections and often experience adverse outcomes. Despite this group being prioritised for vaccination, no COVID-19 vaccine trials recruited CH residents. Given that the social and biological characteristics of CH residents may influence vaccine effectiveness, it is crucial to test vaccines in this population. Methods The Widening Access to Trials in Care Homes (WATCH) project was established to develop best practice guidance on designing and conducting vaccine trials in the CH population. As part of this project, a
Introduction Falls are a common presentation comprising 17% of all ED attendances in older people and can result in harm including fragility fractures (FFs). FFs lead to pain, functional decline, deconditioning, and high mortality. Validated tools such as FRAX can increase prescribing of antiresorptive medications (ARM), reducing harm. Comprehensive geriatric assessment (CGA) is the gold standard for assessing and managing geriatric syndromes including falls and can include fragility fracture risk assessment. Method An audit was conducted of all inpatients over one day on Colwell Ward at Isle
Background A key challenge for disease-modifying trials in Parkinson’s disease (PD) is the lack of sensitive, patient-relevant outcome measures. Digital mobility outcomes (DMOs), captured using body-worn devices, offer a novel, objective means to assess real-world gait and mobility. The Mobilise-D study validated DMOs in PD, demonstrating that the analytics software could accurately and reliably monitor mobility in the real world. However, to progress towards regulatory qualification, demonstration of responsiveness to therapy is required. The Edmond J Safra Accelerating Clinical Trials in